Thu 18 Oct 2018 09:43:47 PM CDT: This site is about to be upgraded to a new software release. During this upgrade you may experience interruptions or delays when entering information. We apologize for any inconvenience this may cause and thank you for your patience during this required update.
2017 marks the second annual Rheumatic Disease Awareness Month (RDAM),
sponsored by the American College of Rheumatology (ACR) and its national
public awareness campaign, Simple Tasks. RDAM is an effort to increase
public understanding and awareness of the
symptoms, risk factors, treatment options, personal and economic
impact, and lifestyle and healthcare challenges associated with
Tri-State chapter (New York, Connecticut, New Jersey) was
recognized as Outstanding Education Program award winner at the 2017
National Patient Education Conference. Tri-State hosted an exceptional
educational event, Kids Gets Scleroderma Too, last
year that drew physicians from five states and 125 participants from
ten states. The Chapter partnered with three pediatric
rheumatologists–each a recipient of a research grant from the
foundation. The conference offered programming for siblings, for
ages 5-12, for teenagers, and for adults.
Make a Plan to Amplify Your Impact: Estate and Planned Giving
you would like to extend your support of the Scleroderma Foundation to
make a lasting impact, there are several gift arrangements to choose
from. Whether you would like to put your donation to work today or
benefit us after your lifetime, you can find a charitable
plan that lets you provide for your family and support the Scleroderma
Contact Deborah Dillon Pearce at
firstname.lastname@example.org for more information about this kind of gift to the Foundation.
Disclaimer: The Scleroderma Foundation in no way
endorses any drugs, treatments, clinical trials, or studies reported in the eLetter. Information is
provided to keep the readers informed. Because the manifestations and severity of scleroderma vary among individuals, personalized medical management is essential. Therefore, it is strongly recommended that all drugs and treatments be discussed with the reader’s physician(s) for proper evaluation and treatment.
The Scleroderma Foundation is a qualified national nonprofit operating under 501(c)(3) status. The foundation’s federal tax identification number is 52-1375827. Our primary goal is to raise funds for our three-fold mission of support, education and research. The foundation has 20 active chapters and 160 support groups across the country.